v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 1,786,759
Prepaid expenses 193,622 25,000
Total current assets 1,980,381 25,000
Deferred offering costs 239,716
Long-term prepaid insurance 63,000
Marketable securities held in Trust Account 256,720,939
Total Assets 258,764,320 264,716
Current liabilities    
Accrued offering costs 75,000 128,386
Accrued expenses 1,179,162 35,884
Total current liabilities 1,254,162 288,920
Deferred underwriting fee 7,590,000
Total Liabilities 8,844,162 288,920
Commitments and Contingencies (Note 6)
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at June 30, 2026 and December 31, 2025
Additional paid-in capital 24,157
Accumulated deficit (6,801,643) (49,204)
Total Shareholders’ Deficit (6,800,781) (24,204) [1]
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit 258,764,320 264,716
Related Party    
Current liabilities    
Promissory note - related party 124,650
Class A Ordinary Shares    
Current liabilities    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,300,000 shares at redemption value of $10.15 per share as of June 30, 2026 and no shares as of December 31, 2025 256,720,939
Shareholders’ Deficit    
Common stock, value 19
Class B Ordinary Shares    
Shareholders’ Deficit    
Common stock, value [2] $ 843 $ 843
[1] Included up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters (see Note 5). On March 12, 2026, the Underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the additional Units occurred on March 16, 2026. As such, on March 16, 2026, the 1,100,000 Class B ordinary shares are no longer subject to forfeiture.
[2] As of December 31, 2025, included up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters (as defined below) (see Note 5). On March 12, 2026, the Underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the additional Units (as defined below) occurred on March 16, 2026. As such, on March 16, 2026, the 1,100,000 Class B ordinary shares are no longer subject to forfeiture.